A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
about
Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseRecognition and Management of Behavioral Disturbances in DementiaNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureThe BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical reviewRecommendations for the management of behavioral and psychological symptoms of dementia.Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.Behavioral and pharmacogenetics of aggressive behavior.Brain serotonin receptors and transporters: initiation vs. termination of escalated aggressionBehavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia.Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006.Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.Update on Alzheimer's disease: recent findings and treatments.Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?Gabapentin for treatment of behavioral and psychological symptoms of dementia.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.The costs of caring: medical costs of Alzheimer's disease and the managed care environment.Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.Association between the APOE genotype and psychopathologic symptoms in Alzheimer's diseasePsychosis in elderly patients: classification and pharmacotherapy.Scales to assess psychosis in Parkinson's disease: Critique and recommendations.Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.Approach to managing behavioural disturbances in dementia.Atypical antipsychotics in Parkinson-sensitive populations.New wine in old bottle: late-life psychosisPharmacologic therapy of dementia with Lewy bodies.Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.Medical management of advanced dementia.Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Regression to the mean: implications for clinical trials of psychotropic agents in dementia.Combination pharmacotherapy in Alzheimer's diseaseEfficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
P2860
Q24244504-9E843EFD-04CA-488B-BEA1-AB3EDA7C9DA1Q24682986-B7A9CA97-9338-431B-9AEC-725DFA2FDDDDQ26864905-0F01BFCF-067F-4FDD-BB83-7BC3270A3453Q27022753-95E2AC57-55EA-4F97-A0B1-2D85D3CCC97FQ30327961-63000524-B3D8-4DDB-BD45-D2F4994B2D3BQ30423717-EE6F5E8F-6E1B-4804-B90D-4A65B6AE0402Q30445754-3D461509-1A4F-489F-BC1C-7C5A6181F0AAQ30453470-6EE54C63-4FE0-4F4F-9081-169DF7E86DAAQ30473431-BA3AD74A-4EED-49B9-81C4-71F8B117B0CBQ30540486-1376D9C4-44D7-4532-A21E-AF24F2FEE1FAQ33203719-557F16FC-095E-44AA-AF11-246531C91CD0Q33233186-25F3D293-C9E0-4E4E-809F-AE315A0BF699Q33483929-F115F5D0-ADE4-437B-9834-022AAD31395EQ33641585-8680745B-8BDC-4B9B-AC16-3BBB9E9904AEQ33727296-4F18CBD0-AD08-49AF-AE93-9538BA622C84Q33892947-7F64EB40-CE68-451D-99C5-6ED1847C7181Q33921338-286301DF-2CEE-4573-9E2A-248B1B43ACDCQ33935882-EBFDA8AF-15E0-416B-BAE8-6585666CE277Q34146983-7E2E360E-B968-44E0-AA3A-1B5CF66A0DC3Q34219064-235DDA72-D484-48F2-B368-D54ECE919F3AQ34298335-3FEB99CE-ED18-4AB6-B694-F073FB4A6DE0Q34452896-B2F4CCA8-BB20-45B4-8F08-B74DA1DD6090Q34465775-F8640A5F-BBAE-47CA-96FB-7C465A1DA166Q34496154-BDF6B536-0F66-438A-A6EB-F8AA1146114BQ34497247-458F0C0A-4981-446B-B488-92D2DD4605EFQ34530796-FFAF49A0-D4A7-4FD8-8E6D-3676E2563D6DQ34543627-A9DED741-9023-44F5-B1EA-D1FA55EA89BEQ34586737-00CF2929-8425-497A-8AED-D27B70180675Q34653780-074456B4-B9A7-46B5-9AF3-E8632AF5D69DQ34683770-C815C673-87D2-4B20-A4C2-FDDA3D81A2AAQ34851726-515D9018-C29B-4898-8959-5A9DAE347372Q34976609-DC9A8890-BC95-4EC5-ABB6-636A4AB09EAAQ35029479-4DF833EC-9088-4345-A756-BC83A8DE1E01Q35109857-EDA19703-07FA-4847-A8D0-BC9FA57F0DF5Q35136544-099239A8-72CD-4E84-9904-35D8E9EF50AEQ35151992-9D50998E-FDF3-4163-9C09-8DF74B0D72C3Q35185368-2E91B953-AC55-4F20-9325-83163F290529Q35211952-3FC90C45-6369-4991-B475-691596A4E147Q35236346-F46F5CD9-D698-4BE7-940C-6355C8E69487Q35499945-BE8AFC1C-8E6F-4DBF-B515-C59EB2290578
P2860
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A randomized trial of risperid ...... havioral symptoms of dementia.
@en
A randomized trial of risperid ...... havioral symptoms of dementia.
@nl
type
label
A randomized trial of risperid ...... havioral symptoms of dementia.
@en
A randomized trial of risperid ...... havioral symptoms of dementia.
@nl
prefLabel
A randomized trial of risperid ...... havioral symptoms of dementia.
@en
A randomized trial of risperid ...... havioral symptoms of dementia.
@nl
P2093
P356
P1433
P1476
A randomized trial of risperid ...... havioral symptoms of dementia.
@en
P2093
Bocksberger JP
Dautzenberg PL
De Deyn PP
Eriksson S
Rasmussen A
P304
P356
10.1212/WNL.53.5.946
P407
P577
1999-09-01T00:00:00Z